These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 12182087

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Ziprasidone in Parkinsonian dopamine psychosis].
    Durán-Ferreras E, Alvarez-López M, García-Moreno JM, Chacón J.
    Rev Neurol; ; 46(8):476-80. PubMed ID: 18428105
    [Abstract] [Full Text] [Related]

  • 24. [Pharmacologic treatment in Parkinson disease].
    García de Yébenes J, Fontán A, Rojo A.
    Neurologia; 1999 May; 14 Suppl 1():17-33. PubMed ID: 10377727
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia.
    Reddy S, Factor SA, Molho ES, Feustel PJ.
    Mov Disord; 2002 Jul; 17(4):676-81. PubMed ID: 12210856
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Diagnosis and therapy of Parkinson's disease].
    Wittstock M, Benecke R.
    MMW Fortschr Med; 2005 May 17; 147 Spec No 2():28-31. PubMed ID: 15968869
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Parkinson syndromes].
    Harlay A.
    Infirm Fr; 1985 Mar 17; (263):20-1. PubMed ID: 3846575
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Peripheral edema and dopamine agonists in Parkinson disease.
    Tan EK.
    Arch Neurol; 2007 Oct 17; 64(10):1546-7; author reply 1547. PubMed ID: 17923645
    [No Abstract] [Full Text] [Related]

  • 37. [Urination disorders and parkinson disease].
    Blanchard-Dauphin A.
    Rev Neurol (Paris); 2009 Feb 17; 165 Spec No 1():F5-10. PubMed ID: 19623702
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Withdrawal of non-dopaminergic antiparkinson drugs].
    Le Bellec M, George V.
    J Toxicol Clin Exp; 1985 Feb 17; 5(1):47-53. PubMed ID: 3843760
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.